Results 161 to 170 of about 21,159,025 (295)

Comorbidity Burden and Prognosis in Patients Aged 80+ Years With Large B-Cell Lymphoma. [PDF]

Clin Lymphoma Myeloma Leuk
Vodička P, Masár M, Thompson CA, Belada D, Cholack GA, Benešová K, Lossos IS, Móciková H, Maláriková D, Williams AM, Procházka V, Polgárová K, Nze CC, Ďuraš J, Kořen J, Cohen JB, Steinerová K, Šálková J, Feldman AL, Karban J, Mou E, Sýkorová A, Kovaříková P, Cahn EJ, Obr A, Konířová E, Martin P, Dlouhá J, Tsang M, Patel D, Blahovcová P, Reagan PM, Jaye D, Klánová M, Friedberg JW, Campr V, Flowers CR, Klener P, Maurer MJ, Habermann TM, Trněný M, Cerhan JR.   +41 more
europepmc   +1 more source

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma

, 2013
Emilia L Lim,1 Marco A Marra1,21Canada’s Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver, BC, Canada; 2Department of Medical Genetics, University of British Columbia, Vancouver, BC, CanadaAbstract: B-cell non-Hodgkin lymphomas ...
Marra MA, Lim EL
core  

Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis

Arthritis &Rheumatology, EarlyView.
Objective To characterize the clinical, immunologic, and proteomic changes associated with CD19 chimeric antigen receptor T cell therapy in patients with progressive systemic sclerosis (SSc). Methods Patients with progressive SSc received CD19 chimeric antigen receptor (CAR)‐T cell therapy and were observed longitudinally for safety, clinical efficacy,
Chenhan Jia, Wanyi Lin, Zhangyi Zhao, Fenglin Wu, Chaoyu Gu, Yuankai Sun, Zhe Ding, Chang Wei, Xinyu Li, Cuiwei Xie, Peng Xia, Zhen Xia, Xuesong Liu, Shaoying Yang, Chunyan Zhang, Hanlin Yin, Liangjing Lu   +16 more
wiley   +1 more source

Intravascular Large B-Cell Lymphoma Presenting as Recurrent Cryptogenic Strokes: A Diagnostic Challenge. [PDF]

Case Rep Hematol
Krishnan V, Dessie H, Stogner K, Baldwin J, Strowd R, Vaidya R, Krishnamurthy S.   +6 more
europepmc   +1 more source

PATHOBIOLOGY OF PRIMARY MEDIASTINAL B-CELL LYMPHOMA

, 2003
Controversy still exists over the response to therapy and prognosis of patients with primary mediastinal B-cell lymphoma (PMBL). Recent data from the International Extranodal Lymphoma Study Group (IELSG) suggest that a MACOP-B (methotrexate, adriamycin ...
PILERI SA, ASCANI S, GAULARD P, ZINZANI PL, SABATTINI E, FALINI B, ZUCCA E, GAIDANO, Gianluca, CAVALLI F., ROSSI M   +9 more
core  

Homocitrullinated Peptides Drive Pro‐Inflammatory T Cell Responses in a Humanized Mouse Model of Rheumatoid Arthritis

Arthritis &Rheumatology, EarlyView.
Objective Anti‐homocitrullinated protein/peptide antibodies are specific to rheumatoid arthritis (RA) and predictive of worse prognosis, suggesting a pathogenic role for autoreactivity to homocitrullinated peptides (HomoCitP). However, T cell responses to HomoCitP remain largely unexplored.
Sofya Ulanova, Jaspreet Kaur, Gabrielle Buckley, S. M. Mansour Haeryfar, Lisa Cameron, Ewa Cairns, Lillian Barra   +6 more
wiley   +1 more source

Primary Colonic Diffuse Large B-cell Lymphoma: A Diagnostic Challenge. [PDF]

Cureus
Montero S.
europepmc   +1 more source

Distinct Molecular Pathways Supporting Sjögren Disease Clusters and Disease Progression

Arthritis &Rheumatology, EarlyView.
Objective Sjögren disease (SjD) is a heterogeneous autoimmune disease. We aimed to investigate blood transcriptomic signatures and disease progression among three recently defined clusters of patients with SjD: (1) B cell active disease with low symptom burden (BALS), (2) high systemic activity (HSA), and (3) low systemic activity with high symptom ...
Sacha E. Silva‐Saffar, Yann Nguyen, Raphaèle Seror, Jacques‐Eric Gottenberg, Anna Niarakis, Xavier Mariette, Gaetane Nocturne   +6 more
wiley   +1 more source

Correction: SETD1B mutations confer apoptosis resistance and BCL2 independence in B cell lymphoma. [PDF]

J Exp Med
Portelinha A, Wang S, Parsa S, Jiang M, Gorelick AN, Mohanty S, Sharma S, de Stanchina E, Berishaj M, Zhao C, Heward J, Aryal NK, Tavana O, Wen J, Fitzgibbon J, Dogan A, Younes A, Melnick AM, Wendel HG.   +18 more
europepmc   +1 more source

Peripheral Blood DNA Methylation Changes Precede Lymphoma Diagnosis in Primary Sjögren's Disease

Arthritis &Rheumatology, EarlyView.
Objective Primary Sjögren's disease (SjD) is a systemic autoimmune disease associated with an increased risk of lymphoma. The molecular mechanisms underlying lymphomagenesis remain poorly understood, and sensitive biomarkers for early identification of patients at high risk of developing lymphoma are lacking.
Hanna Lidberg, Cecilia Fugmann, Juliana Imgenberg‐Kreuz   +2 more
wiley   +1 more source